TARIS BIOMEDICAL

taris-biomedical-logo

TARIS Biomedical develops new therapies designed for the treatment of difficult-to-treat bladder diseases. The company's system is designed to continuously release drugs in the bladder over weeks to months and is deployed and retrieved using minimally-invasive, in-office procedures, enabling drug release to be tailored to match the needs of each disease.

#SimilarOrganizations #People #Financial #Website #More

TARIS BIOMEDICAL

Social Links:

Industry:
Biotechnology Health Care Pharmaceutical Therapeutics

Founded:
2008-01-01

Address:
Lexington, Massachusetts, United States

Country:
United States

Website Url:
http://www.tarisbiomedical.com

Total Employee:
11+

Status:
Active

Contact:
+1 781 676 7750

Email Addresses:
[email protected]

Total Funding:
113.09 M USD

Technology used in webpage:
SPF Amazon Amazon Virginia Region


Similar Organizations

aclaris-therapeutics-logo

Aclaris Therapeutics

Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.

amicus-therapeutics-logo

Amicus Therapeutics

Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases.

evrys-bio-logo

Evrys Bio

Evrys Bio is a pharmaceutical company for providing health care solutions to defend against the virus.

livwell-logo

LivWell

LivWell is dispensary company that provides exceptional cannabis products.

molecular-templates-logo

Molecular Templates

Molecular Templates develops novel therapeutic compounds for cancer.

recro-pharma-logo

Recro Pharma

Recro Pharma is a pharmaceutical company developing non-opioid therapeutics for the treatment of pain.

scout-bio-logo

Scout Bio

Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.

silver-creek-pharmaceuticals-logo

Silver Creek Pharmaceuticals

Silver Creek Pharmaceuticals is a biotechnology company, develops protein therapeutics to treat cardiovascular diseases.

vintabio-logo

VintaBio

VintaBio is a life sciences company that offers cell and gene therapy manufacturing services.

xeris-pharmaceuticals-logo

Xeris Pharmaceuticals

Xeris Pharmaceuticals is a pharmaceutical company that develops therapies for patients in endocrinology, neurology, and gastroenterology.


Current Advisors List

dennis-ausiello_image

Dennis Ausiello Member of the Board of Directors @ TARIS Biomedical
Board_member

cary-pfeffer_image

Cary Pfeffer Board Member @ TARIS Biomedical
Board_member

kevin-finney_image

Kevin Finney Board Member @ TARIS Biomedical
Board_member

kevin-bitterman_image

Kevin Bitterman Board of Directors @ TARIS Biomedical
Board_member
2008-01-01

jeff-bussgang_image

Jeff Bussgang Member of the Board of Directors @ TARIS Biomedical
Board_member
2014-01-01

edwin-kania_image

Edwin Kania Member of the Board of Directors @ TARIS Biomedical
Board_member

Current Employees Featured

michael-cima_image

Michael Cima
Michael Cima Director @ TARIS Biomedical
Director
2008-01-01

christopher-j-searcy_image

Christopher J. Searcy
Christopher J. Searcy Chief Medical Officer @ TARIS Biomedical
Chief Medical Officer

not_available_image

Robert S. Langer
Robert S. Langer Director @ TARIS Biomedical
Director

dennis-h-giesing_image

Dennis H. Giesing
Dennis H. Giesing Chief Scientific Officer @ TARIS Biomedical
Chief Scientific Officer
2008-11-01

Founder


paul-janssen_image

Paul Janssen

Investors List

roman-abramovich_image

Roman Abramovich

Roman Abramovich investment in Series B - TARIS Biomedical

millhouse-capital_image

Millhouse

Millhouse investment in Series B - TARIS Biomedical

flagship-ventures_image

Flagship Pioneering

Flagship Pioneering investment in Series B - TARIS Biomedical

polaris-partners_image

Polaris Partners

Polaris Partners investment in Series B - TARIS Biomedical

bristol-myers-squibb_image

Bristol-Myers Squibb

Bristol-Myers Squibb investment in Series B - TARIS Biomedical

yongyong-investment_image

Yonghua Capital

Yonghua Capital investment in Series B - TARIS Biomedical

ra-capital-management_image

RA Capital Management

RA Capital Management investment in Series B - TARIS Biomedical

yonjin-venture_image

Yonjin Venture

Yonjin Venture investment in Series A - TARIS Biomedical

ra-capital-management_image

RA Capital Management

RA Capital Management investment in Venture Round - TARIS Biomedical

flagship-ventures_image

Flagship Pioneering

Flagship Pioneering investment in Venture Round - TARIS Biomedical

Official Site Inspections

http://www.tarisbiomedical.com

  • Host name: a6033b2998aeb1ff7.awsglobalaccelerator.com
  • IP address: 99.83.186.106
  • Location: Seattle United States
  • Latitude: 47.54
  • Longitude: -122.3032
  • Metro Code: 819
  • Timezone: America/Los_Angeles
  • Postal: 98108

Loading ...

More informations about "TARIS Biomedical"

TARIS Biomedical - Crunchbase Company Profile

TARIS Biomedical develops new therapies designed for the treatment of difficult-to-treat bladder diseases. The company's system is designed to continuously release drugs in the bladder over weeks to months and is deployed and โ€ฆSee details»

Taris Biomedical - VentureRadar

TARIS Biomedical LLC was formed as part of the transaction between TARIS Biomedical, Inc., and Allergan in August 2014. This new entity retained the management team, pipeline โ€ฆSee details»

Taris Biomedical LLC Company Profile - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for Taris Biomedical LLC of Lexington, MA. Get the latest business insights from Dun & Bradstreet.See details»

Taris Biomedical (US) - PitchBook

Apr 2, 2013 Taris Biomedical (US) General Information Description. Developer of targeted new therapies designed for the treatment of difficult-to-treat bladder diseases. The company's โ€ฆSee details»

Taris Biomedical - Company Profile - Tracxn

Nov 15, 2024 Taris Biomedical - Drug delivery device for bladder diseases. Acquired by Johnson & Johnson. Raised a total funding of $109M over 6 rounds from 8 investors. Founded by โ€ฆSee details»

TARIS Biomedical - Flagship Pioneering

TARIS Biomedical® was founded in 2008 in response to a long-standing clinical need for a convenient, safe, and effective way to treat bladder disease locally. Encouraged by the โ€ฆSee details»

TARIS Biomedical - Overview, News & Similar companies - ZoomInfo

Dec 20, 2019 Johnson & Johnson (NYSE: JNJ) acquired Taris Biomedical, a privately-owned biotechnology company specializing in the development of a novel drug delivery โ€ฆSee details»

TARIS Biomedical - Org Chart, Teams, Culture & Jobs - The Org

TARIS Biomedical is a leader in the local sustained delivery of therapeutics to the genitourinary system. Industries. Pharmaceutical. Headquarters. Lexington, United States. Stage. Series B. โ€ฆSee details»

TARIS Biomedical Company Profile - Office Locations ... - Craft

TARIS Biomedical was founded in 2008 in response to a long-standing clinical need for a convenient, safe, and effective way to treat bladder disease locally. Encouraged by the โ€ฆSee details»

Johnson & Johnson acquires TARIS Biomedical - 2019-12-20

Dec 20, 2019 TARIS Biomedical TARIS Biomedical is a pharmaceutical company developing therapies for genitourinary system issues. Acquiring Organization: Johnson & Johnson โ€ฆSee details»

TARIS Biomedical - Company Profile & Staff Directory - ContactOut

TARIS Biomedical a specialty pharmaceutical company with deep domain expertise in therapeutics and drug-delivery, is focused on local minimally-invasive drug-device โ€ฆSee details»

Taris Biomedical - PitchBook

Taris Biomedical is headquartered in Woburn, MA. What is the size of Taris Biomedical? Taris Biomedical has 8 total employees. What industry is Taris Biomedical in? Taris Biomedicalโ€™s โ€ฆSee details»

TARIS Biomedical - Contacts, Employees, Board Members

Organization. TARIS Biomedical . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. ... About. TARIS Biomedical has 4 current employee profiles, โ€ฆSee details»

TARIS Biomedical | Scientist.com

TARIS Biomedical® is a product-focused drug delivery company treating genitourinary conditions with deep domain expertise in the local delivery and sustained release of therapeutics to target โ€ฆSee details»

Johnson & Johnson Acquires TARIS Biomedical with Focus on โ€ฆ

NEW BRUNSWICK, N.J., Dec. 20, 2019 /PRNewswire/ -- Johnson & Johnson announced today the acquisition of TARIS Biomedical LLC (TARIS), a privately-owned biotechnology company โ€ฆSee details»

TARIS Biomedical® Raises $32 Million andโ€ฆ | Flagship Pioneering

Oct 27, 2015 LEXINGTON, Mass.--(BUSINESS WIRE)--TARIS Biomedical LLC, a company using proprietary delivery technology and deep expertise in bladder biology to develop novel โ€ฆSee details»

Johnson & Johnson Acquires TARIS Biomedical ... - Flagship โ€ฆ

NEW BRUNSWICK, NJ, December 20, 2019 โ€“ Johnson & Johnson announced today the acquisition of TARIS Biomedical LLC (TARIS), a privately-owned biotechnology company โ€ฆSee details»

TARIS - Janssen

2 days ago A small pretzel-shaped device designed as a novel approach for the treatment of bladder cancer attracted Janssen Oncology to TARIS Biomedical in 2019 and ultimately led to โ€ฆSee details»

TARIS Biomedical LLC | Insights

Oct 8, 2024 Already A Biomedtracker Subscriber? You have access to the full company record through your subscription.See details»

TARIS Biomedical® Launches Second Phase 1b Clinical Trial of โ€ฆ

Business Wire: August 10, 2016 โ€“ LEXINGTON, MA, U.S.A. โ€“ TARIS Biomedical, a company developing powerful and targeted new treatments for millions of patients suffering from difficult โ€ฆSee details»

linkstock.net © 2022. All rights reserved